| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Teesta Valley Tea Company Limited |
|
Particulars |
31-03-2024 |
31-03-2023 |
|
Non-current assets |
|
|
|
Property, plant and equipment |
2,00,762.17 |
2,02,310.82 |
|
Capital work-in-progress |
19,447.87 |
13,494.37 |
|
Intangible assets |
44.51 |
73.33 |
|
Loans |
3,609.64 |
3,558.48 |
|
Other Financial Assets (net) |
123.57 |
123.57 |
|
Non-Current tax assets (net) |
2,076.19 |
2,650.37 |
|
Deferred Tax assets |
2,501.15 |
2,588.92 |
|
Other non-current assets |
315.13 |
830.00 |
|
Current assets |
|
|
|
Inventories |
1,10,772.86 |
83,377.59 |
|
Biological Assets other than Bearer
Plants |
67,827.60 |
53,626.55 |
|
Trade Receivables |
345.99 |
- |
|
Cash and Cash equivalents |
1,045.53 |
636.59 |
|
Loans |
2,151.02 |
2,151.02 |
|
Other financial assets |
14,735.51 |
13,803.34 |
|
Current tax assets (net) |
5,739.84 |
4,213.11 |
|
Other Current Assets |
1,480.41 |
849.44 |
|
Total Assets |
4,32,978.98 |
3,84,287.50 |
|
Equity |
|
|
|
Equity
Share capital |
1,500 |
1,500 |
|
Reserves and surplus |
96,934.67 |
1,17,173.43 |
|
Non-Current liabilities |
|
|
|
Borrowings |
11,519.33 |
11,784.78 |
|
Current liabilities |
|
|
|
Borrowings |
1,43,746.55 |
1,14,712.04 |
|
Trade Payables |
20,983.66 |
22,232.65 |
|
Other Financial Liabilities |
7,851.92 |
9,773.57 |
|
Other Current liabilities |
1,50,442.85 |
1,07,111.03 |
|
Total Equity and Liabilities |
4,32,978.98 |
3,84,287.50 |
|
Particulars |
31-03-2024 |
31-03-2023 |
|
Revenue from Operation |
1,39,169.17 |
1,72,675.51 |
|
Other Income |
693.94 |
2,846.85 |
|
Total
Income |
1,39,863.11 |
1,75,522.36 |
|
Expenses |
|
|
|
Change in inventories of finished goods
|
(29,264.22) |
16,113.03 |
|
Change in biological assets |
(14,201.05) |
(29,232.45) |
|
Employee Benefit Expense |
1,31,086.89 |
1,37,550.14 |
|
Finance Cost |
10,044.68 |
9,204.47 |
|
Depreciation and Amortisation Expense |
4,056.67 |
4,301.81 |
|
Other Expenses |
58,291.13 |
59,345.82 |
|
Total
Expense |
1,60,014.09 |
1,97,282.81 |
|
Profit/Loss
before tax |
(20,150.98) |
(21,760.45) |
|
Deferred tax including MAT (depreciation) |
87.78 |
91.18 |
|
Profit
for the year |
(20,238.76) |
(21,851.63) |
|
Total
comprehensive Income/(Loss) for the year |
(20,238.76) |
(21,851.63) |
|
Earnings
per Equity Share |
|
|
|
Before exceptional items (Basic &
Diluted) |
(0.13) |
(0.15) |
|
After exceptional ordinary items (Basic
& Diluted) |
(0.13) |
(0.15) |
|
31-03-2024 |
31-03-2023 |
|
|
Cash Flow from
Operating Activities |
|
|
|
Net Profit before Tax and extraordinary items |
(20,150.98) |
(21,760.45) |
|
Adjustments for: |
|
|
|
Depreciation |
4,056.67 |
4,301.81 |
|
Interest income |
(315.70) |
(254.30) |
|
Interest expenses |
10,044.68 |
9,204.47 |
|
Operating Profit
before Working Capital Charges |
(6,365.34) |
(8,508.47) |
|
Adjustments for |
|
|
|
Trade &
Current Receivables |
(1,909.13) |
(1,358.27) |
|
Inventories |
(27,395.27) |
(17,746.26) |
|
Biological assets |
(14,201.05) |
(29,232.45) |
|
Trade &
Current payables |
40,161.18 |
31,268.29 |
|
Cash Generated from Operations |
(9,709.61) |
9,915.36 |
|
Direct tax paid |
(952.56) |
(1,383.40) |
|
Net Cash Generated
from Operating Activates |
(10,662.17) |
8,531.95 |
|
Cash Flow from
Investing Activities |
|
|
|
Payment against acquisition of fixed assets including payment against capital liability |
(8,432.69) |
(16,490.90) |
|
Long term
borrowings |
(51.16) |
(51.02) |
|
Investments
realisation/ (made) during the year |
(315.13) |
(830.00) |
|
Net Cash Used in
Investing Activities |
(8,798.98) |
(17,371.92) |
|
Cash flow from financing activities |
|
|
|
Proceeds from short-term
borrowings |
29,034.51 |
18,175.07 |
|
Interest received |
197.61 |
211.96 |
|
Interest paid |
(9,096.59) |
(9,352.88) |
|
Long term loan
received |
(265.46) |
(248.85) |
|
Net cash flow generated/ (used in) from financing
activities |
19,870.08 |
8,785.29 |
|
Net Increase /(Decrease) In Cash
and Cash Equivalents |
408.94 |
(54,67) |
|
Cash & Cash
Equivalents at the Beginning of the Year |
4,400.59 |
4,455.27 |
|
Cash & Cash
Equivalents at the End of the Year |
4,809.53 |
4,400.59 |
Here is a summary of the Cash Flow Statement for the years 2024 and 2023:
Cash
Flow from Operating Activities
For the year ending 31st March 2024, the company
recorded a negative cash flow of ₹10,662.17 thousand from operating activities,
compared to a positive ₹8,531.95 thousand in 2023. Even though there was some
help from depreciation (₹4,056.67 thousand) and interest expenses (₹10,044.68
thousand), large increases in inventories (₹27,395.27 thousand) and biological
assets (₹14,201.05 thousand) pulled cash out of the business. The decrease was
also affected by lower trade receivables collection.
Cash
Flow from Investing Activities
The company had a net outflow of ₹8,798.98 thousand
in 2024, better than the outflow of ₹17,371.92 thousand in 2023. The main cash
usage was for fixed asset purchases (₹8,432.69 thousand) and investment
purchases (₹315.13 thousand), with very little inflow from other sources.
Cash
Flow from Financing Activities
Financing activities generated ₹19,870.08 thousand
in 2024, up from ₹8,785.29 thousand in 2023. The inflow was largely from
short-term borrowings (₹29,034.51 thousand) and interest received (₹197.61
thousand), which outweighed outflows from interest paid (₹9,096.59 thousand)
and small repayments of long-term loans.
Net
Change in Cash and Cash Equivalents
Overall, the company’s cash position increased by
₹408.94 thousand in 2024, compared to a decrease of ₹54.67 thousand in 2023.The
closing cash balance stood at ₹4,809.53 thousand, up from ₹4,400.59 thousand
the year before, indicating a small but positive improvement in liquidity
despite negative operating cash flow.
|
2024 |
2023 |
|
|
Current Ratio |
0.63 |
0.63 |
|
Debt-Equity Ratio |
0.12 |
0.10 |
|
Debt Service
Coverage Ratio |
(0.09) |
(0.21) |
|
Return on Equity |
(0.19) |
(0.17) |
|
Inventory Turnover
Ratio |
0.24 |
0.76 |
|
Trade Receivables
Turnover Ratio |
402.24 |
- |
|
Trade Payables
Turnover Ratio |
0.15 |
0.13 |
|
Net Capital
Turnover Ratio |
(1.17) |
(1.81) |
|
Net Profit Ratio |
(0.15) |
(0.13) |
|
Return on Capital
Employed |
(0.88) |
(1.07) |
Here is a summary of the Financial Ratios for the years 2024 and 2023:
Current Ratio
The
current ratio remained unchanged at 0.63 in both 2023 and 2024. This is well
below the ideal benchmark of 1, meaning the company’s current assets are not
sufficient to cover its short-term liabilities. This weak liquidity position
suggests the company may face challenges in meeting immediate financial
obligations without raising additional funds.
Debt-Equity Ratio
The
debt-equity ratio increased slightly from 0.10 to 0.12. While the change is
small, it shows a slight increase in the use of debt compared to equity.
However, the overall debt level remains low, which reduces the financial risk
from borrowings.
Debt Service Coverage Ratio
The ratio
improved from –0.21 in 2023 to –0.09 in 2024. Even though this is a small
improvement, the ratio remains negative, meaning the company is still not
generating enough operating earnings to cover its debt obligations, which can
be a serious concern for lenders and investors.
Return on Equity (ROE)
ROE fell
slightly from –0.17 to –0.19, indicating that the losses relative to
shareholders’ equity have worsened. A negative ROE means the company is not
delivering value to shareholders and instead is eroding equity.
Inventory Turnover Ratio
This
ratio dropped significantly from 0.76 to 0.24, showing that inventory is moving
at a much slower pace than before. Slow inventory turnover can lead to higher
storage costs, potential obsolescence, and tied-up capital.
Trade Receivables Turnover Ratio
The ratio
is reported as extremely high at 402.24 in 2024, with no data for 2023. Such an
unusually high figure might indicate that the company is collecting payments
from customers almost instantly or has minimal receivables, which could be due
to advance payments or cash sales.
Trade Payables Turnover Ratio
The ratio
improved slightly from 0.13 to 0.15, showing that the company is paying its
suppliers a little faster. While faster payments can strengthen supplier
relationships, it can also reduce available cash if not managed properly.
Net Capital Turnover Ratio
The ratio
improved from –1.81 to –1.17, but it remains negative. This indicates the
company is not efficiently using its capital to generate sales, and performance
is still below healthy levels.
Net Profit Ratio
The net
profit ratio worsened from –0.13 to –0.15, meaning the company’s losses as a
percentage of sales have increased. This shows declining profitability and the
need for better cost and revenue management.
Return on Capital Employed (ROCE)
ROCE
improved slightly from –1.07 to –0.88. Despite the improvement, the negative
figure indicates the company is still not generating positive returns from the
total capital employed in the business.